PeptideStack
5.2kquestions
20kanswers
220users

How do I reconcile 98.2% from Medutest with 96.4% from the supplier?

Asked 22 Aug 2025Modified 9 months agoViewed 12k times
23

What I am working with: 98.2% · Medutest · 96.4%.

This is not behaving the way I expected and I want to understand the discrepancy before I act on it.

I have photographed the current state and recorded the conditions, so I can answer follow-up questions precisely.

Should I be treating this as a failure or as noise?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
NP
askednet_peptide16k1722 Aug 2025

2 Answers

Accepted answer first, then by votes
54

Accepted answer

The method matters more than the vial, which is why specifying a method buys you far more than changing suppliers does.

Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.

It helps to be literal here: sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.

Compare purity within a single laboratory on the same method, never across laboratories.

edited 7 Oct 2025 by meniscus_film — updated for the 2026 guidance change

shareimprove this answerflag
MF
answered · acceptedmeniscus_film34k386 Oct 2025
4I would gently push back on the second point — the evidence there is thinner than stated. – charge_state_3 7 months ago
5Adding for future readers: the certificate should carry the lot number, not just a batch code. – Dr_Priya_Raghunathan 9 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
20

Area percentage is not mass percentage, and conflating the two is the most common misreading of a purity figure.

Retention time is sequence-specific and method-specific, so comparing your result to a supplier value using a different method is meaningless without method documentation.

Detection wavelength matters because 214 nm sees the peptide backbone while 280 nm sees only aromatic side chains — so truncation impurities lacking a tryptophan are invisible at 280 nm.

Proline conformer interconversion kinetics are well-characterised and the half-life is of the same order as the chromatographic peak width at room temperature.

I would be careful about over-reading a single measurement — treat it as a data point, not as ground truth.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
C8
answeredcoldpack_8837k3817 Oct 2025
8Useful. I have added the accept threshold suggestion to my own notes. – Dr_Otto_Lindqvist 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.